The real-world effectiveness of ustekinumab in patients with ulcerative colitis in the United States
Overall, ustekinumab is an effective treatment for UC in real-world clinical practice capable of inducing and maintaining long-term remission. Future work should assess how ustekinumab impacts quality of life.
Authors
- Sabree Burbage
- William E. Jones (ORCID: https://orcid.org/0000-0003-2126-5211)
- Rachael Meadows (ORCID: https://orcid.org/0000-0001-9047-4733)
- Sumesh Kachroo (ORCID: https://orcid.org/0000-0002-7190-6323)
- Hannah Knight (ORCID: https://orcid.org/0000-0002-8379-4381)
- Ruizhi Zhao (ORCID: https://orcid.org/0000-0002-6447-1093)
- Bridget Godwin
Institutions
- Janssen (Belgium) (BE)
- Adelphi Group (United Kingdom) (GB)
- Janssen Scientific Affairs (United States)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/03007995.2025.2494642
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82